GLUCOBAY Side Effects

7018537-8 | Arrhythmia, Chest Discomfort, Dyspnoea, Palpitations
on Aug 23, 2010 Female patient from CHINA , 70 years of age, was diagnosed with diabetes mellitus, hypertension and was treated with Glucobay (View Usage). Patient experienced the following unwanted or unexpected effects: arrhythmia (What is arrhythmia?), chest discomfort, dyspnoea, palpitations. Glucobay dosage: Total Daily Dose: 50 Mg. During the same period patient was treated with GLIPIZIDE (View Glipizide Review and Glipizide Label ), METFORMIN (View Metformin Review and Metformin Label ), FELODIPINE (View Felodipine Review and Felodipine Label ), INSULIN (View Insulin Review and Insulin Label ). Patient was hospitalized.

6992348-1 | Arrhythmia, Chest Discomfort, Dyspnoea, Palpitations
Patient was taking Glucobay (View Usage). Patient had the following side effects: arrhythmia (What is arrhythmia?), chest discomfort, dyspnoea, palpitations on Sep 10, 2010 from SWITZERLAND Additional patient health information: Female patient , 70 years of age, was diagnosed with diabetes mellitus, hypertension and. Glucobay dosage: Total Daily Dose: 50 Mg. During the same period patient was treated with GLIPIZIDE (View Glipizide Review and Glipizide Label ), METFORMIN (View Metformin Review and Metformin Label ), FELODIPINE (View Felodipine Review and Felodipine Label ), INSULIN (View Insulin Review and Insulin Label ). Patient was hospitalized.

6967803-0 | Arrhythmia
Adverse event was reported on Aug 23, 2010 by a Female patient taking Glucobay (View Usage) (Dosage: Total Daily Dose: 50 Mg) was diagnosed with diabetes mellitus, hypertension and. Location: SWITZERLAND , 70 years of age, After Glucobay was administered, patient had the following side effects: arrhythmia (What is arrhythmia?). During the same period patient was treated with GLIPIZIDE (View Glipizide Review and Glipizide Label ), METFORMIN (View Metformin Review and Metformin Label ), FELODIPINE (View Felodipine Review and Felodipine Label ), INSULIN (View Insulin Review and Insulin Label ).

6965054-7 | Arrhythmia
on Aug 23, 2010 Female patient from SWITZERLAND , 70 years of age, was diagnosed with diabetes mellitus, hypertension and was treated with Glucobay (View Usage). Patient experienced the following unwanted or unexpected effects: arrhythmia (What is arrhythmia?). Glucobay dosage: Total Daily Dose: 50 Mg. During the same period patient was treated with GLIPIZIDE (View Glipizide Review and Glipizide Label ), METFORMIN (View Metformin Review and Metformin Label ), FELODIPINE (View Felodipine Review and Felodipine Label ), REGULAR INSULIN (View Regular Insulin Review and Regular Insulin Label ).


6938530-0 | Blood Glucose Increased
on Aug 09, 2010 Male patient from CHINA , 66 years of age, was diagnosed with diabetes mellitus and was treated with Glucobay (View Usage). Patient had the following side effects: blood glucose increased. Glucobay dosage: Unit Dose: 150 Mg. During the same period patient was treated with INSULIN (View Insulin Review and Insulin Label ). Patient was hospitalized.

6938526-9 | Blood Glucose Increased
Patient was taking Glucobay (View Usage). After Glucobay was administered, patient had the following side effects: blood glucose increased on Aug 09, 2010 from CHINA Additional patient health information: Female patient , 80 years of age, was diagnosed with diabetes mellitus and. Glucobay dosage: Unit Dose: 50 Mg. During the same period patient was treated with NOVOLIN R (View Novolin R Review and Novolin R Label ), PIOGLITAZONE (View Pioglitazone Review and Pioglitazone Label ), KABOPING (View Kaboping Review and Kaboping Label ). Patient was hospitalized.

6936007-X | Blood Glucose Increased
Adverse event was reported on Aug 09, 2010 by a Male patient taking Glucobay (View Usage) (Dosage: Unit Dose: 150 Mg) was diagnosed with diabetes mellitus and. Location: CHINA , 66 years of age, Patient experienced the following unwanted or unexpected effects: blood glucose increased. During the same period patient was treated with INSULIN (View Insulin Review and Insulin Label ). Patient was hospitalized.

6781646-2 | Diarrhoea, Intestinal Haemorrhage
on Jun 07, 2010 Female patient from VIET NAM , 72 years of age, weighting 134.5 lb, was diagnosed with diabetes mellitus, hypertension and was treated with Glucobay (View Usage). Patient had the following side effects: diarrhoea, intestinal haemorrhage. Glucobay dosage: Total Daily Dose: 150 Mg. During the same period patient was treated with INSULIN MIXTARD (View Insulin Mixtard Review and Insulin Mixtard Label ), COVERSYL PLUS (View Coversyl Plus Review and Coversyl Plus Label ), ZANEDIP (Total Daily Dose: 10 Mg Unit Dose: 10 Mg) (View Zanedip Review and Zanedip Label ).

6770535-5 | Diarrhoea, Intestinal Haemorrhage
on May 28, 2010 Female patient from VIET NAM , 72 years of age, weighting 134.5 lb, was diagnosed with diabetes mellitus, hypertension and was treated with Glucobay (View Usage). After Glucobay was administered, patient had the following side effects: diarrhoea, intestinal haemorrhage. Glucobay dosage: Total Daily Dose: 150 Mg. During the same period patient was treated with INSULIN MIXTARD (View Insulin Mixtard Review and Insulin Mixtard Label ), COVERSYL PLUS (View Coversyl Plus Review and Coversyl Plus Label ), ZANEDIP (Total Daily Dose: 10 Mg Unit Dose: 10 Mg) (View Zanedip Review and Zanedip Label ).

6762984-6 | Diarrhoea, Intestinal Haemorrhage
Patient was taking Glucobay (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, intestinal haemorrhage on May 28, 2010 from VIET NAM Additional patient health information: Female patient , 72 years of age, weighting 134.5 lb, was diagnosed with diabetes mellitus, hypertension and. Glucobay dosage: Total Daily Dose: 150 Mg. During the same period patient was treated with INSULIN MIXTARD (View Insulin Mixtard Review and Insulin Mixtard Label ), COVERSYL PLUS (View Coversyl Plus Review and Coversyl Plus Label ), ZANEDIP (Total Daily Dose: 10 Mg Unit Dose: 10 Mg) (View Zanedip Review and Zanedip Label ).

6749088-3 | Cardiac Failure Congestive, Glomerulonephritis Rapidly Progressive, Nephritis Autoimmune
Adverse event was reported on May 07, 2010 by a Male patient taking Glucobay (View Usage) (Dosage: Total Daily Dose: 300 Mg Unit Dose: 100 Mg) was diagnosed with type 2 diabetes mellitus, hypertension and. Location: JAPAN , 50 years of age, weighting 141.1 lb, Patient had the following side effects: cardiac failure congestive, glomerulonephritis rapidly progressive, nephritis autoimmune. During the same period patient was treated with ADALAT CC (Unit Dose: 20 Mg) (View Adalat Cc Review and Adalat Cc Label ), FLUITRAN (Unit Dose: 2 Mg) (View Fluitran Review and Fluitran Label ).

6749087-1 | Hypoglycaemia
on May 06, 2010 Female patient from FRANCE , 88 years of age, weighting 127.9 lb, was diagnosed with type 2 diabetes mellitus, hypertension and was treated with Glucobay (View Usage). After Glucobay was administered, patient had the following side effects: hypoglycaemia. Glucobay dosage: Total Daily Dose: 50 Mg Unit Dose: 50 Mg. During the same period patient was treated with METFORMIN HCL (Total Daily Dose: 1000 Mg Unit Dose: 1000 Mg) (View Metformin Hcl Review and Metformin Hcl Label ), LANTUS (Total Daily Dose: 18 Iu) (View Lantus Review and Lantus Label ), NOVONORM (Total Daily Dose: 8 Mg) (View Novonorm Review and Novonorm Label ), DIOVAN HCT (Total Daily Dose: 80 Mg Unit Dose: 80 Mg) (View Diovan Hct Review and Diovan Hct Label ). Patient was hospitalized.

6749084-6 | Pneumatosis Intestinalis
on Apr 28, 2010 Male patient from JAPAN , 91 years of age, weighting 132.3 lb, was diagnosed with diabetes mellitus and was treated with Glucobay (View Usage). Patient experienced the following unwanted or unexpected effects: pneumatosis intestinalis. Glucobay dosage: . During the same period patient was treated with AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), ISOSORBIDE DINITRATE (View Isosorbide Dinitrate Review and Isosorbide Dinitrate Label ), PRANLUKAST HYDRATE (View Pranlukast Hydrate Review and Pranlukast Hydrate Label ), CARBOCISTEINE (View Carbocisteine Review and Carbocisteine Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ). Patient was hospitalized.

6749083-4 | Pneumatosis Intestinalis
Patient was taking Glucobay (View Usage). Patient had the following side effects: pneumatosis intestinalis on May 07, 2010 from JAPAN Additional patient health information: Female patient , 79 years of age, weighting 85.98 lb, was diagnosed with diabetes mellitus and. Glucobay dosage: Unit Dose: 100 Mg. During the same period patient was treated with DILTIAZEM HYDROCHLORIDE (View Diltiazem Hydrochloride Review and Diltiazem Hydrochloride Label ), MENTORIES (View Mentories Review and Mentories Label ), BENIDIPINE HYDROCHLORIDE (View Benidipine Hydrochloride Review and Benidipine Hydrochloride Label ), DIOVAN (View Diovan Review and Diovan Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ALSETIN (View Alsetin Review and Alsetin Label ), STANZOME OD (View Stanzome Od Review and Stanzome Od Label ). Patient was hospitalized.

6749071-8 | Blood Creatine Phosphokinase Increased
Adverse event was reported on May 24, 2010 by a Male patient taking Glucobay (View Usage) (Dosage: Total Daily Dose: 300 Mg Unit Dose: 100 Mg) was diagnosed with diabetes mellitus and. Location: JAPAN , 75 years of age, After Glucobay was administered, patient had the following side effects: blood creatine phosphokinase increased. During the same period patient was treated with ACTOS (Total Daily Dose: 15 Mg) (View Actos Review and Actos Label ).

6739725-1 | Blood Creatine Phosphokinase Increased
on May 24, 2010 Male patient from JAPAN , 75 years of age, was diagnosed with diabetes mellitus and was treated with Glucobay (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased. Glucobay dosage: Total Daily Dose: 300 Mg Unit Dose: 100 Mg. During the same period patient was treated with ACTOS (Total Daily Dose: 15 Mg) (View Actos Review and Actos Label ).

6732480-0 | Gastrooesophageal Reflux Disease, Pneumatosis Intestinalis
on May 07, 2010 Female patient from JAPAN , 79 years of age, weighting 85.98 lb, was diagnosed with diabetes mellitus and was treated with Glucobay (View Usage). Patient had the following side effects: gastrooesophageal reflux disease, pneumatosis intestinalis. Glucobay dosage: Unit Dose: 100 Mg. During the same period patient was treated with DILTIAZEM HYDROCHLORIDE (View Diltiazem Hydrochloride Review and Diltiazem Hydrochloride Label ), MENTORIES (View Mentories Review and Mentories Label ), BENIDIPINE HYDROCHLORIDE (View Benidipine Hydrochloride Review and Benidipine Hydrochloride Label ), DIOVAN (View Diovan Review and Diovan Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ALSETIN (View Alsetin Review and Alsetin Label ), STANZOME OD (View Stanzome Od Review and Stanzome Od Label ). Patient was hospitalized.

6730958-7 | Hypoglycaemia
Patient was taking Glucobay (View Usage). After Glucobay was administered, patient had the following side effects: hypoglycaemia on May 06, 2010 from GERMANY Additional patient health information: Female patient , 88 years of age, weighting 127.9 lb, was diagnosed with type 2 diabetes mellitus, hypertension and. Glucobay dosage: Total Daily Dose: 50 Mg Unit Dose: 50 Mg. During the same period patient was treated with METFORMIN HYDROCHLORIDE (Total Daily Dose: 1000 Mg Unit Dose: 1000 Mg) (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), LANTUS (Total Daily Dose: 18 Iu) (View Lantus Review and Lantus Label ), NOVONORM (Total Daily Dose: 8 Mg) (View Novonorm Review and Novonorm Label ), DIOVAN HCT (Total Daily Dose: 80 Mg Unit Dose: 80 Mg) (View Diovan Hct Review and Diovan Hct Label ). Patient was hospitalized.

6669290-9 | Cardiac Failure Congestive, Glomerulonephritis Rapidly Progressive, Renal Impairment
Adverse event was reported on Mar 25, 2010 by a Male patient taking Glucobay (View Usage) (Dosage: Total Daily Dose: 300 Mg Unit Dose: 100 Mg) was diagnosed with type 2 diabetes mellitus, hypertension and. Location: JAPAN , 49 years of age, weighting 141.1 lb, Patient experienced the following unwanted or unexpected effects: cardiac failure congestive, glomerulonephritis rapidly progressive, renal impairment. During the same period patient was treated with ADALAT CC (Unit Dose: 20 Mg) (View Adalat Cc Review and Adalat Cc Label ), FLUITRAN (Unit Dose: 2 Mg) (View Fluitran Review and Fluitran Label ). Patient was hospitalized and became disabled.

6619078-X | Portal Venous Gas
on Jan 26, 2010 Male patient from JAPAN , 57 years of age, was diagnosed with diabetes mellitus, bronchitis (What is bronchitis?) and was treated with Glucobay (View Usage). Patient had the following side effects: portal venous gas. Glucobay dosage: . During the same period patient was treated with ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ).

6614990-X | Hypoglycaemia
on Dec 24, 2008 Male patient from JAPAN , 61 years of age, weighting 110.2 lb, was diagnosed with post gastric surgery syndrome and was treated with Glucobay (View Usage). After Glucobay was administered, patient had the following side effects: hypoglycaemia. Glucobay dosage: .

6574077-1 | Portal Venous Gas
Patient was taking Glucobay (View Usage). Patient experienced the following unwanted or unexpected effects: portal venous gas on Jan 26, 2010 from JAPAN Additional patient health information: Male patient , 57 years of age, was diagnosed with diabetes mellitus, bronchitis (What is bronchitis?) and. Glucobay dosage: . During the same period patient was treated with ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ).

6534054-3 | Intestinal Obstruction, Urinary Retention
Adverse event was reported on Nov 09, 2009 by a Male patient taking Glucobay (View Usage) (Dosage: Total Daily Dose: 300 Mg) was diagnosed with schizophrenia and. Location: UNITED STATES , 66 years of age, Patient had the following side effects: intestinal obstruction, urinary retention. During the same period patient was treated with CHLORPROMAZINE (Total Daily Dose: 75 Mg) (View Chlorpromazine Review and Chlorpromazine Label ), VASOLAN (Start Date: Before 2000) (View Vasolan Review and Vasolan Label ), MAGNESIUM OXIDE (Total Daily Dose: 1.5 G) (View Magnesium Oxide Review and Magnesium Oxide Label ), ABILIFY (Total Daily Dose: 24 Mg) (View Abilify Review and Abilify Label ).

6534053-1 | Hypoglycaemia, Loss Of Consciousness
on Nov 09, 2009 Male patient from GERMANY , 85 years of age, weighting 198.4 lb, was diagnosed with type 2 diabetes mellitus, cardiac failure, hypertension, bronchitis chronic, hypercholesterolaemia and was treated with Glucobay (View Usage). After Glucobay was administered, patient had the following side effects: hypoglycaemia, loss of consciousness. Glucobay dosage: Total Daily Dose: 50 Mg Unit Dose: 50 Mg. During the same period patient was treated with ACTRAPHANE HM (Total Daily Dose: 22 Iu) (View Actraphane Hm Review and Actraphane Hm Label ), ACTRAPID HUMAN (As Used: 22-20-18 Iu) (View Actrapid Human Review and Actrapid Human Label ), AQUAPHOR 20 (Total Daily Dose: 40 Mg Unit Dose: 40 Mg) (View Aquaphor 20 Review and Aquaphor 20 Label ), DELIX (Total Daily Dose: 5 Mg Unit Dose: 5 Mg) (View Delix Review and Delix Label ), DIGITOXIN INJ (Total Daily Dose: 0.07 Mg Unit Dose: 0.07 Mg) (View Digitoxin Inj Review and Digitoxin Inj Label ), THEOPHYLLINE (Total Daily Dose: 750 Mg Unit Dose: 375 Mg) (View Theophylline Review and Theophylline Label ), EXFORGE 5/160 (Total Daily Dose: 5 Mg Unit Dose: 5 Mg) (View Exforge 5/160 Review and Exforge 5/160 Label ), INEGY (Total Daily Dose: 10 Mg Unit Dose: 10 Mg) (View Inegy Review and Inegy Label ). Patient was hospitalized.

6448571-8 | Intestinal Obstruction, Urinary Retention
on Nov 09, 2009 Male patient from UNITED STATES , 66 years of age, was diagnosed with schizophrenia and was treated with Glucobay (View Usage). Patient experienced the following unwanted or unexpected effects: intestinal obstruction, urinary retention. Glucobay dosage: Total Daily Dose: 300 Mg. During the same period patient was treated with CHLORPROMAZINE (Total Daily Dose: 75 Mg) (View Chlorpromazine Review and Chlorpromazine Label ), VASOLAN (Start Date: Before 2000) (View Vasolan Review and Vasolan Label ), MAGNESIUM OXIDE (Total Daily Dose: 1.5 G) (View Magnesium Oxide Review and Magnesium Oxide Label ), ABILIFY (Total Daily Dose: 24 Mg) (View Abilify Review and Abilify Label ).

6448569-X | Hypoglycaemia, Loss Of Consciousness
Patient was taking Glucobay (View Usage). Patient had the following side effects: hypoglycaemia, loss of consciousness on Nov 09, 2009 from GERMANY Additional patient health information: Male patient , 85 years of age, weighting 198.4 lb, was diagnosed with type 2 diabetes mellitus, cardiac failure, hypertension, bronchitis chronic, hypercholesterolaemia and. Glucobay dosage: Total Daily Dose: 50 Mg Unit Dose: 50 Mg. During the same period patient was treated with ACTRAPHANE HM (Total Daily Dose: 22 Iu) (View Actraphane Hm Review and Actraphane Hm Label ), ACTRAPID HUMAN (As Used: 22-20-18 Iu) (View Actrapid Human Review and Actrapid Human Label ), AQUAPHOR 20 (Total Daily Dose: 40 Mg Unit Dose: 40 Mg) (View Aquaphor 20 Review and Aquaphor 20 Label ), DELIX (Total Daily Dose: 5 Mg Unit Dose: 5 Mg) (View Delix Review and Delix Label ), DIGITOXIN INJ (Total Daily Dose: 0.07 Mg Unit Dose: 0.07 Mg) (View Digitoxin Inj Review and Digitoxin Inj Label ), THEOPHYLLINE (Total Daily Dose: 750 Mg Unit Dose: 375 Mg) (View Theophylline Review and Theophylline Label ), EXFORGE 5/160 (Total Daily Dose: 5 Mg Unit Dose: 5 Mg) (View Exforge 5/160 Review and Exforge 5/160 Label ), INEGY (Total Daily Dose: 10 Mg Unit Dose: 10 Mg) (View Inegy Review and Inegy Label ). Patient was hospitalized.

6201123-7 | Abdominal Distension, Anorexia, Constipation, Erectile Dysfunction, Hepatic Function Abnormal, Hypoglycaemic Coma, Oliguria, Renal Failure, Somnolence
Adverse event was reported on May 19, 2009 by a Male patient taking Glucobay (View Usage) (Dosage: Total Daily Dose: 150 Mg) was diagnosed with diabetes mellitus and. Location: CHINA , 82 years of age, After Glucobay was administered, patient had the following side effects: abdominal distension, anorexia, constipation (What is constipation?), erectile dysfunction (What is erectile dysfunction?), hepatic function abnormal, hypoglycaemic coma, oliguria, renal failure, somnolence. Patient was hospitalized.

6198903-3 | Abdominal Distension, Anorexia, Constipation, Erectile Dysfunction, Hepatic Function Abnormal, Hypoglycaemic Coma, Oliguria, Renal Failure, Somnolence
on May 13, 2009 Male patient from CHINA , 82 years of age, was diagnosed with diabetes mellitus and was treated with Glucobay (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, anorexia, constipation (What is constipation?), erectile dysfunction (What is erectile dysfunction?), hepatic function abnormal, hypoglycaemic coma, oliguria, renal failure, somnolence. Glucobay dosage: Total Daily Dose: 150 Mg. Patient was hospitalized.

6192475-5 | Pancytopenia
on May 13, 2009 Female patient from JAPAN , 76 years of age, weighting 136.7 lb, was diagnosed with diabetes mellitus, hypertension and was treated with Glucobay (View Usage). Patient had the following side effects: pancytopenia. Glucobay dosage: Total Daily Dose: 150 Mg Unit Dose: 50 Mg. During the same period patient was treated with ADALAT CC (Total Daily Dose: 40 Mg Unit Dose: 20 Mg) (View Adalat Cc Review and Adalat Cc Label ), OLMETEC (View Olmetec Review and Olmetec Label ), PERSANTINE (View Persantine Review and Persantine Label ), BERIZYM (View Berizym Review and Berizym Label ), KOLANTYL (View Kolantyl Review and Kolantyl Label ), LIPITOR (View Lipitor Review and Lipitor Label ), SANCOBA (View Sancoba Review and Sancoba Label ), NIFLAN (View Niflan Review and Niflan Label ).

6179274-5 | Hypoglycaemic Coma
Patient was taking Glucobay (View Usage). After Glucobay was administered, patient had the following side effects: hypoglycaemic coma on Apr 27, 2009 from CHINA Additional patient health information: Male patient , 82 years of age, was diagnosed with diabetes mellitus and. Glucobay dosage: Total Daily Dose: 150 Mg.

6164729-X | Pancytopenia
Adverse event was reported on Apr 21, 2009 by a Female patient taking Glucobay (View Usage) (Dosage: Total Daily Dose: 150 Mg Unit Dose: 50 Mg) was diagnosed with diabetes mellitus, hypertension and. Location: JAPAN , 76 years of age, weighting 136.7 lb, Patient experienced the following unwanted or unexpected effects: pancytopenia. During the same period patient was treated with ADALAT CC (Total Daily Dose: 40 Mg Unit Dose: 20 Mg) (View Adalat Cc Review and Adalat Cc Label ), OLMETEC (View Olmetec Review and Olmetec Label ), PERSANTINE (View Persantine Review and Persantine Label ), BERIZYM (View Berizym Review and Berizym Label ), KOLANTYL (View Kolantyl Review and Kolantyl Label ), LIPITOR (View Lipitor Review and Lipitor Label ), SANCOBA (View Sancoba Review and Sancoba Label ), NIFLAN (View Niflan Review and Niflan Label ).

6160026-7 | Oedema Peripheral, Palpitations, Respiratory Distress
on Apr 08, 2009 Female patient from CANADA , 81 years of age, weighting 366.0 lb, was treated with Glucobay (View Usage). Patient had the following side effects: oedema peripheral, palpitations, respiratory distress. Glucobay dosage: Total Daily Dose: 150 Mg Unit Dose: 50 Mg. During the same period patient was treated with APO ATENOL (View Apo-atenol Review and Apo-atenol Label ), APO RAMIPRIL (View Apo-ramipril Review and Apo-ramipril Label ), AVANDIA (View Avandia Review and Avandia Label ), COUMADIN (View Coumadin Review and Coumadin Label ), EURO CAL D (View Euro-cal D Review and Euro-cal D Label ), EURO FER (View Euro-fer Review and Euro-fer Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), LIPITOR (View Lipitor Review and Lipitor Label ).

6159009-2 | Breast Cancer
on Apr 08, 2009 Female patient from CANADA , 53 years of age, weighting 141.1 lb, was treated with Glucobay (View Usage). After Glucobay was administered, patient had the following side effects: breast cancer (What is breast cancer?). Glucobay dosage: Total Daily Dose: 100 Mg Unit Dose: 100 Mg. During the same period patient was treated with ACTOS (View Actos Review and Actos Label ), AVAPRO (Total Daily Dose: 75 Mg Unit Dose: 75 Mg) (View Avapro Review and Avapro Label ), DIAMICRON (Total Daily Dose: 30 Mg Unit Dose: 30 Mg) (View Diamicron Review and Diamicron Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), LANTUS (View Lantus Review and Lantus Label ), LIPITOR (View Lipitor Review and Lipitor Label ), METFORMIN HCL (Total Daily Dose: 500 Mg Unit Dose: 500 Mg) (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

6146101-1 | Hypoglycaemic Coma
Patient was taking Glucobay (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemic coma on Mar 31, 2009 from JAPAN Additional patient health information: Female patient , 82 years of age, weighting 101.4 lb, was diagnosed with type 2 diabetes mellitus, pyrexia and. Glucobay dosage: Total Daily Dose: 300 Mg Unit Dose: 100 Mg. During the same period patient was treated with CRAVIT (Total Daily Dose: 300 Mg Unit Dose: 100 Mg) (View Cravit Review and Cravit Label ), AMLODIPINE (Total Daily Dose: 5 Mg Unit Dose: 5 Mg) (View Amlodipine Review and Amlodipine Label ), MAGNESIUM OXIDE (After Breakfast) (View Magnesium Oxide Review and Magnesium Oxide Label ), MYSLEE (Total Daily Dose: 5 Mg) (View Myslee Review and Myslee Label ). Patient was hospitalized and became disabled.

6110869-0 | Hypoglycaemic Coma, Pyrexia
Adverse event was reported on Feb 25, 2009 by a Female patient taking Glucobay (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus, pyrexia and. Location: JAPAN , 82 years of age, Patient had the following side effects: hypoglycaemic coma, pyrexia. During the same period patient was treated with LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ). Patient was hospitalized and became disabled.

6107288-X | Hypoglycaemic Coma
on Feb 25, 2009 Female patient from JAPAN , 82 years of age, was diagnosed with type 2 diabetes mellitus, pyrexia and was treated with Glucobay (View Usage). After Glucobay was administered, patient had the following side effects: hypoglycaemic coma. Glucobay dosage: . During the same period patient was treated with LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ). Patient was hospitalized and became disabled.

6088542-7 | Abdominal Distension, Asthenia, Chills, Chromaturia, Hepatitis Acute, Hyperbilirubinaemia, Jaundice, Nausea, Pyrexia
on Feb 12, 2009 Male patient from TAIWAN, PROVINCE OF CHINA , 51 years of age, weighting 136.7 lb, was diagnosed with type 2 diabetes mellitus, hypertension, hyperlipidaemia, osteonecrosis (What is osteonecrosis?) and was treated with Glucobay (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, asthenia, chills, chromaturia, hepatitis acute, hyperbilirubinaemia, jaundice (What is jaundice?), nausea (What is nausea?), pyrexia. Glucobay dosage: Total Daily Dose: 150 Mg Unit Dose: 50 Mg. During the same period patient was treated with METFORMIN (View Metformin Review and Metformin Label ), OLMESARTAN MEDOXOMIL (Unit Dose: 20 Mg) (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ), BOKEY (Unit Dose: 100 Mg) (View Bokey Review and Bokey Label ), FENOLIP (Unit Dose: 200 Mg) (View Fenolip Review and Fenolip Label ), ADALAT (Unit Dose: 30 Mg) (View Adalat Review and Adalat Label ), MELOXIN (Unit Dose: 7.5 Mg) (View Meloxin Review and Meloxin Label ), NORFLEX (Unit Dose: 100 Mg) (View Norflex Review and Norflex Label ). Patient was hospitalized.

6078841-7 | Abdominal Distension, Asthenia, Chills, Chromaturia, Hepatitis Acute, Hyperbilirubinaemia, Jaundice, Nausea, Pyrexia
Patient was taking Glucobay (View Usage). Patient had the following side effects: abdominal distension, asthenia, chills, chromaturia, hepatitis acute, hyperbilirubinaemia, jaundice (What is jaundice?), nausea (What is nausea?), pyrexia on Feb 02, 2009 from TAIWAN, PROVINCE OF CHINA Additional patient health information: Male patient , 51 years of age, weighting 136.7 lb, was diagnosed with type 2 diabetes mellitus, hypertension, hyperlipidaemia, osteonecrosis (What is osteonecrosis?) and. Glucobay dosage: Unit Dose: 50 Mg. During the same period patient was treated with METFORMIN HCL (Unit Dose: 500 Mg) (View Metformin Hcl Review and Metformin Hcl Label ), OLMESARTAN MEDOXOMIL (Unit Dose: 20 Mg) (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ), BOKEY (Unit Dose: 100 Mg) (View Bokey Review and Bokey Label ), FENOLIP (Unit Dose: 200 Mg) (View Fenolip Review and Fenolip Label ), ADALAT (Unit Dose: 30 Mg) (View Adalat Review and Adalat Label ), MELOXIN (Unit Dose: 7.5 Mg) (View Meloxin Review and Meloxin Label ), NORFLEX (Unit Dose: 100 Mg) (View Norflex Review and Norflex Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ). Patient was hospitalized.

6076531-8 | Abdominal Distension, Asthenia, Chills, Chromaturia, Hepatitis Acute, Hyperbilirubinaemia, Jaundice, Nausea, Pyrexia
Adverse event was reported on Feb 02, 2009 by a Male patient taking Glucobay (View Usage) (Dosage: Unit Dose: 50 Mg) was diagnosed with type 2 diabetes mellitus, hypertension, hyperlipidaemia, osteonecrosis (What is osteonecrosis?) and. Location: TAIWAN, PROVINCE OF CHINA , 51 years of age, weighting 136.7 lb, After Glucobay was administered, patient had the following side effects: abdominal distension, asthenia, chills, chromaturia, hepatitis acute, hyperbilirubinaemia, jaundice (What is jaundice?), nausea (What is nausea?), pyrexia. During the same period patient was treated with METFORMIN HCL (Unit Dose: 500 Mg) (View Metformin Hcl Review and Metformin Hcl Label ), OLMESARTAN MEDOXOMIL (Unit Dose: 20 Mg) (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ), BOKEY (Unit Dose: 100 Mg) (View Bokey Review and Bokey Label ), FENOLIP (Unit Dose: 200 Mg) (View Fenolip Review and Fenolip Label ), ADALAT (Unit Dose: 30 Mg) (View Adalat Review and Adalat Label ), MELOXIN (Unit Dose: 7.5 Mg) (View Meloxin Review and Meloxin Label ), NORFLEX (Unit Dose: 100 Mg) (View Norflex Review and Norflex Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ). Patient was hospitalized.

6060893-1 | Hypoglycaemia
on Dec 24, 2008 Male patient from JAPAN , 61 years of age, weighting 110.2 lb, was diagnosed with post gastric surgery syndrome and was treated with Glucobay (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia. Glucobay dosage: .

6043073-5 | Hypoglycaemia
on Jan 13, 2009 Male patient from GERMANY , 85 years of age, weighting 198.4 lb, was diagnosed with type 2 diabetes mellitus, cardiac failure, hypertension, bronchitis chronic, hypercholesterolaemia, polyneuropathy and was treated with Glucobay (View Usage). Patient had the following side effects: hypoglycaemia. Glucobay dosage: Total Daily Dose: 150 Mg Unit Dose: 50 Mg. During the same period patient was treated with ACTRAPHANE HM (View Actraphane Hm Review and Actraphane Hm Label ), AQUAPHOR 20 (Total Daily Dose: 40 Mg Unit Dose: 40 Mg) (View Aquaphor 20 Review and Aquaphor 20 Label ), DELIX (Total Daily Dose: 5 Mg Unit Dose: 5 Mg) (View Delix Review and Delix Label ), DIGITOXIN TAB (Total Daily Dose: 0.07 Mg Unit Dose: 0.07 Mg) (View Digitoxin Tab Review and Digitoxin Tab Label ), THEOPHYLLINE (Total Daily Dose: 750 Mg Unit Dose: 375 Mg) (View Theophylline Review and Theophylline Label ), EXFORGE 5/160 (Total Daily Dose: 5 Mg Unit Dose: 5 Mg) (View Exforge 5/160 Review and Exforge 5/160 Label ), INEGY (Total Daily Dose: 10 Mg Unit Dose: 10 Mg) (View Inegy Review and Inegy Label ), LYRICA (Total Daily Dose: 150 Mg Unit Dose: 75 Mg) (View Lyrica Review and Lyrica Label ). Patient was hospitalized.

6043065-6 | Hypoglycaemia
Patient was taking Glucobay (View Usage). After Glucobay was administered, patient had the following side effects: hypoglycaemia on Jan 09, 2009 from GERMANY Additional patient health information: Female patient , 88 years of age, weighting 127.9 lb, was diagnosed with type 2 diabetes mellitus, hypertension and. Glucobay dosage: Total Daily Dose: 50 Mg Unit Dose: 50 Mg. During the same period patient was treated with METFORMIN (Total Daily Dose: 1000 Mg Unit Dose: 1000 Mg) (View Metformin Review and Metformin Label ), LANTUS (Total Daily Dose: 18 Iu) (View Lantus Review and Lantus Label ), NOVONORM (Total Daily Dose: 8 Mg) (View Novonorm Review and Novonorm Label ), DIOVAN HCT (Total Daily Dose: 80 Mg Unit Dose: 80 Mg) (View Diovan Hct Review and Diovan Hct Label ).

6026799-9 | Hypoglycaemia
Adverse event was reported on Dec 24, 2008 by a Male patient taking Glucobay (View Usage) (Dosage: ) was diagnosed with post gastric surgery syndrome and. Location: JAPAN , 61 years of age, weighting 110.2 lb, Patient experienced the following unwanted or unexpected effects: hypoglycaemia.

5940169-0 | Weight Decreased
on Oct 22, 2008 Male patient from CHINA , 60 years of age, weighting 99.21 lb, was diagnosed with diabetes mellitus, cystitis noninfective and was treated with Glucobay (View Usage). Patient had the following side effects: weight decreased. Glucobay dosage: Total Daily Dose: 150 Mg. During the same period patient was treated with AZITHROMYCIN (Total Daily Dose: 0.75 G) (View Azithromycin Review and Azithromycin Label ).

5917504-2 | Abdominal Distension, Megacolon, Subileus
on Oct 06, 2008 Male patient from JAPAN , 75 years of age, weighting 183.0 lb, was diagnosed with diabetes mellitus and was treated with Glucobay (View Usage). After Glucobay was administered, patient had the following side effects: abdominal distension, megacolon, subileus. Glucobay dosage: Total Daily Dose: 300 Mg Unit Dose: 100 Mg. During the same period patient was treated with ATELEC (View Atelec Review and Atelec Label ), DIOVAN (View Diovan Review and Diovan Label ).

5805487-5 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Gamma-glutamyltransferase Increased, Liver Disorder
Patient was taking Glucobay (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, liver disorder on Jul 01, 2008 from JAPAN Additional patient health information: Female patient , 56 years of age, weighting 138.9 lb, was diagnosed with diabetes mellitus and. Glucobay dosage: Total Daily Dose: 150 Mg Unit Dose: 50 Mg.

5802454-2 | Gastric Cancer
Adverse event was reported on Dec 27, 1995 by a Male patient taking Glucobay (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus and. Location: JAPAN , 59 years of age, weighting 160.9 lb, Patient had the following side effects: gastric cancer. During the same period patient was treated with GLIBENCLAMIDE (View Glibenclamide Review and Glibenclamide Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ), DILTIAZEM HCL (View Diltiazem Hcl Review and Diltiazem Hcl Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ). Patient was hospitalized.

5797003-1 | Gastric Cancer
on Dec 27, 1995 Male patient from JAPAN , 59 years of age, weighting 160.9 lb, was diagnosed with type 2 diabetes mellitus and was treated with Glucobay (View Usage). After Glucobay was administered, patient had the following side effects: gastric cancer. Glucobay dosage: . During the same period patient was treated with GLIBENCLAMIDE (View Glibenclamide Review and Glibenclamide Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ), DILTIAZEM HCL (View Diltiazem Hcl Review and Diltiazem Hcl Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ). Patient was hospitalized.

5773465-0 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Gamma-glutamyltransferase Increased, Liver Disorder
on Jun 09, 2008 Female patient from JAPAN , 56 years of age, was diagnosed with diabetes mellitus and was treated with Glucobay (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, liver disorder. Glucobay dosage: Total Daily Dose: 150 Mg Unit Dose: 50 Mg.

5773461-3 | Facial Palsy, Headache
Patient was taking Glucobay (View Usage). Patient had the following side effects: facial palsy, headache (What is headache?) on Jun 09, 2008 from JAPAN Additional patient health information: Male patient , 60 years of age, weighting 143.3 lb, was diagnosed with diabetes mellitus and. Glucobay dosage: Total Daily Dose: 300 Mg Unit Dose: 100 Mg. During the same period patient was treated with EUGLUCON (View Euglucon Review and Euglucon Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), MEVALOTIN (View Mevalotin Review and Mevalotin Label ), DIOVAN (View Diovan Review and Diovan Label ).